Hypercytokinemia in Hemophagocytic Syndrome
Hypercytokinemia in Hemophagocytic Syndrome
复制标题
噬血细胞综合征中的高细胞因子血症
DOI:
10.1097/00043426-199302000-00012
复制
发表时间:
1993
期刊:
影响因子:
--
通讯作者:
S. Imashuku
中科院分区:
文献类型:
--
作者:
F. Fujiwara;S. Hibi;S. Imashuku
Purpose The study was performed to clarify in the hemophagocytic syndrome (HPS) how cytokinemia plays a role in its pathogenesis and if cytokinemia is of prognostic value. Patients and Methods : Serum concentrations of ferritin, inteiferon (IFN)-γ, soluble interleukin-2 (IL-2) receptor, IL-6, and other cytokines were determined during the acute phase of the HPS in 29 children and three adults. Data comparing malignancy-associated (MAHS; n = 17) and infection-associated hemophagocytic syndrome (IAHS; n = 15) and those comparing surviving and fatal cases were assessed. Results : Hyperferritinemia and hypercytokinemia were present in all patients with HPS. Eleven of the 17 MAHS and three of the 15 IAHS cases were fatal (p < 0.05). No significant difference in cytokine concentrations was observed between MAHS and IAHS. Conclusions : In terms of cytokine effect on patient outcome, serum concentrations of IL-6 >300 ng/L and IFN-γ concentrations >30 U/ml or soluble IL-2 receptor (sIL-2R) concentrations >10,000 U/ml were considered to reflect a poor prognosis in HPS patients.